dotatate
Generic: dotatate·Brand: Lutathera
dotatate: 2 clinical trials tracked.
dotatate evidence translation
What we can confirm
2 tracked trials
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about dotatate, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (2)
A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With Inoperable, Progressive, Well Differentiated, Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumours
Primary endpoint: Progression Free Survival (PFS) assessed by BIRC
InterventionalRandomizedopen196 targetStarted 2022-08Completion 2028-1223 sites · ChinaSinotau Pharmaceutical Group
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
Primary endpoint: progression-free survival
Interventionalopen130 targetStarted 2017-10Completion 2033-011 site · United StatesNational Cancer Institute (NCI)